Practice question

Answer the question and get instant feedback.

ModerateEndocrinologyType 2 diabetes with CVD – SGLT2 useuk-plab-1

A 58-year-old man with type 2 diabetes on Metformin and Gliclazide has an HbA1c of 68 mmol/mol despite good adherence. He has established cardiovascular disease. According to NICE guidance, which additional drug class should be considered to improve glycaemic control and reduce cardiovascular risk?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.